Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

SEER

Seer (SEER)

Seer Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:SEER
DateTimeSourceHeadlineSymbolCompany
05/08/20243:35PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:SEERSeer Inc
05/08/20243:15PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:SEERSeer Inc
05/08/20243:05PMGlobeNewswire Inc.Seer Reports First Quarter 2024 Financial ResultsNASDAQ:SEERSeer Inc
05/08/20243:03PMGlobeNewswire Inc.Seer Launches New Technology Access Center in Europe to Expand Accessibility to Unbiased Proteomic SolutionsNASDAQ:SEERSeer Inc
04/23/20243:05PMGlobeNewswire Inc.Seer to Report First Quarter 2024 Financial Results on May 8, 2024NASDAQ:SEERSeer Inc
03/06/20243:14PMEdgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:SEERSeer Inc
02/29/20243:15PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:SEERSeer Inc
02/29/20243:05PMGlobeNewswire Inc.Seer Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Full Year 2024 OutlookNASDAQ:SEERSeer Inc
02/23/20244:30PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SEERSeer Inc
02/21/20243:05PMGlobeNewswire Inc.Seer to Participate in the TD Cowen 44th Annual Health Care ConferenceNASDAQ:SEERSeer Inc
02/07/20248:05PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SEERSeer Inc
02/06/20247:00AMGlobeNewswire Inc.Seer Proteograph™ Enables Unprecedented Genetic Marker Mapping for Proteogenomics Studies to Advance Drug and Biomarker DiscoveryNASDAQ:SEERSeer Inc
02/01/20243:05PMGlobeNewswire Inc.Seer to Report Fourth Quarter and Full Year 2023 Financial Results on February 29, 2024NASDAQ:SEERSeer Inc
01/03/20247:52AMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:SEERSeer Inc
12/22/20233:10PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:SEERSeer Inc
12/21/20233:05PMGlobeNewswire Inc.Seer to Present at the J.P. Morgan 42nd Annual Health Care ConferenceNASDAQ:SEERSeer Inc
11/17/20233:58PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:SEERSeer Inc
11/10/20238:00AMGlobeNewswire Inc.Seer to Present at the Canaccord MedTech, Diagnostics and Digital Health & Services ForumNASDAQ:SEERSeer Inc
11/08/20238:00AMGlobeNewswire Inc.Seer Wins Proteomics Solution of the Year by BioTech Breakthrough and Named #5 on Deloitte Technology Fast 500NASDAQ:SEERSeer Inc
11/07/20233:25PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:SEERSeer Inc
11/07/20233:18PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:SEERSeer Inc
11/07/20233:05PMGlobeNewswire Inc.Seer Reports Third Quarter 2023 Financial ResultsNASDAQ:SEERSeer Inc
11/01/20238:00AMGlobeNewswire Inc.Seer Announces Addition of Panome Bio to Centers of Excellence (COE) ProgramNASDAQ:SEERSeer Inc
10/19/20233:05PMGlobeNewswire Inc.Seer to Report Third Quarter 2023 Financial Results on November 7, 2023NASDAQ:SEERSeer Inc
09/08/20233:05PMGlobeNewswire Inc.Seer to Participate in Upcoming September Investor ConferencesNASDAQ:SEERSeer Inc
08/08/20233:21PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:SEERSeer Inc
08/08/20233:15PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:SEERSeer Inc
08/08/20233:05PMGlobeNewswire Inc.Seer Reports Second Quarter 2023 Financial ResultsNASDAQ:SEERSeer Inc
07/27/20233:05PMGlobeNewswire Inc.Seer to Present at the Canaccord Genuity 43rd Annual Growth ConferenceNASDAQ:SEERSeer Inc
07/21/20233:29PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:SEERSeer Inc
 Showing the most relevant articles for your search:NASDAQ:SEER